# LFSC holdings: all 39 positions

> All 39 LFSC holdings with weights, as of May 31, 2026. The top 3 are TVTX 7.67%, COGT 7.53% and LIVN 7.11%. Download the full list as a CSV.

Data as of May 31, 2026. Rebuilt every trading night.

LFSC held 39 positions as of May 31, 2026. Travere Therapeutics Inc is the largest at 7.67%; the top 10 are 54.7% of the fund.

Source: Form N-PORT filed with the SEC (https://www.sec.gov/Archives/edgar/data/831114/000119312526319618/primary_doc.xml).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Travere Therapeutics Inc | TVTX | 7.67% |
| 2 | Cogent Biosciences Inc | COGT | 7.53% |
| 3 | LivaNova PLC | LIVN | 7.11% |
| 4 | Spyre Therapeutics Inc | SYRE | 6.41% |
| 5 | Guardant Health Inc | GH | 5.52% |
| 6 | Mirum Pharmaceuticals Inc | MIRM | 4.92% |
| 7 | Corcept Therapeutics Inc | CORT | 4.79% |
| 8 | United Therapeutics Corp | UTHR | 4.16% |
| 9 | VeraDermics Inc | MANE | 3.42% |
| 10 | Savara Inc | SVRA | 3.22% |
| 11 | Cytokinetics Inc | CYTK | 3.16% |
| 12 | Nektar Therapeutics | NKTR | 3.14% |
| 13 | Trevi Therapeutics Inc | TRVI | 3.12% |
| 14 | Dianthus Therapeutics Inc | DNTH | 3.09% |
| 15 | Axsome Therapeutics Inc | AXSM | 2.84% |
| 16 | Billiontoone Inc | BLLN | 2.73% |
| 17 | TransMedics Group Inc | TMDX | 2.68% |
| 18 | Viridian Therapeutics Inc | VRDN | 2.23% |
| 19 | ICU Medical Inc | ICUI | 2.09% |
| 20 | Corvus Pharmaceuticals Inc | CRVS | 1.95% |
| 21 | Palvella Therapeutics Inc | PVLA | 1.95% |
| 22 | Ceribell Inc | CBLL | 1.55% |
| 23 | Globus Medical Inc | GMED | 1.27% |
| 24 | Xeris Biopharma Holdings Inc | XERS | 1.22% |
| 25 | Bridgebio Pharma Inc | BBIO | 1.17% |
| | Cash and other net assets | | −0.04% |

The largest 25 of 39 positions are shown. All of them: https://etfiq.com/funds/lfsc/holdings/lfsc-holdings.csv (CSV) or https://etfiq.com/data/books/lfsc.json (JSON).

Fund page: https://etfiq.com/funds/lfsc

Cite: ETFIQ, Holdings of LFSC, data as of May 31, 2026. https://etfiq.com/funds/lfsc/holdings/